XYLOCAINE 2 %, gel urethral in a pre-filled syringe syringe, 10 g
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Gelsyringe, 10 gurétrale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XYLOCAINE 2 %, gel urétral en seringue préremplie
- Pharmaceutical form
- gel
- Route of administration
- urétrale
- Presentation description
- 1 seringue(s) préremplie(s) polypropylène de 10 g
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Jun 2004
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66652284CIP73634461CIP133400936344617Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LIDOCAÏNEgel | 2,132 g · 100 g de gel | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREgel | 2,000 g · 100 g de gel | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.